More Americans are turning to peptides for muscle building, skin rejuvenation, and to try and live longer even though the ...
The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.
First it was Ozempic, now it's peptides. What to know about the latest wellness craze promoted by influencers and celebrities ...
Results of CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in RCC, were presented at JADPRO 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback